BioCentury
ARTICLE | Financial News

Cell Therapeutics completes private placement of convertible preferred stock

October 8, 2012 7:00 AM UTC

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash. Business: Cancer, Hematology Date completed: 10/5/12 Type: Private placement of convertible preferred stock Raised: $60 million Shares:...